tiprankstipranks
Trending News
More News >
Dexcom (DXCM)
:DXCM
US Market
Advertisement

Dexcom (DXCM) Technical Analysis

Compare
4,291 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Dexcom’s (DXCM) Moving Averages Convergence Divergence (MACD) indicator is -2.33, suggesting Dexcom is a Sell.
Dexcom’s (DXCM) 20-Day exponential moving average is 67.99, while Dexcom’s (DXCM) share price is $66.33, making it a Sell.
Dexcom’s (DXCM) 50-Day exponential moving average is 72.36, while Dexcom’s (DXCM) share price is $66.33, making it a Sell.

Dexcom (DXCM) Pivot Points

Oct 18, 2025, 03:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
62.96
63.93
64.67
65.64
66.38
67.35
68.09
Fibonacci
63.93
64.58
64.99
65.64
66.29
66.70
67.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dexcom (DXCM) Moving Averages

Oct 18, 2025, 03:42 AM
Period
Simple
Exponential
MA5
65.65Buy
66.05Buy
MA10
66.36Sell
66.44Sell
MA20
66.90Sell
67.99Sell
MA50
73.61Sell
72.36Sell
MA100
78.89Sell
75.54Sell
MA200
78.86Sell
76.79Sell
Dexcom’s (DXCM) 10-Day exponential moving average is 66.44, while Dexcom’s (DXCM) share price is $66.33, making it a Sell.
Dexcom’s (DXCM) 100-Day exponential moving average is 75.54, while Dexcom’s (DXCM) share price is $66.33, making it a Sell.
Dexcom’s (DXCM) stock price is $66.33 and Dexcom’s (DXCM) 50-day simple moving average is 73.61, creating a Sell signal.
Dexcom’s (DXCM) stock price is $66.33 and Dexcom’s (DXCM) 100-day simple moving average is 78.89, creating a Sell signal.
Dexcom’s (DXCM) stock price is $66.33 and Dexcom’s (DXCM) 200-day simple moving average is 78.86, creating a Sell signal.

Dexcom (DXCM) Technical Indicators

Oct 18, 2025, 03:42 AM
Name
Value
Implied Action
RSI (14)
40.19
Neutral
STOCH (9,6)
48.03
Neutral
STOCHRSI (14)
46.79
Neutral
MACD (12,26)
-2.33
Sell
ADX (14)
39.37
Neutral
Williams %R
-45.99
Buy
CCI (14)
-67.95
Neutral
ATR (14)
2.52
-
Ultimate Oscillator
50.84
Neutral
ROC
-1.15
Sell
Dexcom’s (DXCM) Relative Strength Index (RSI) is 40.19, creating a Neutral signal.
Dexcom’s (DXCM) Trend Strength Indicator (ADX) is 39.37, creating a Neutral signal.
Dexcom’s (DXCM) Commodity Channel Index (CCI) is -67.95, creating a Neutral signal.
Dexcom’s (DXCM) Price Rate of Change (ROC) is -1.15, creating a Sell signal.

FAQ

Is DXCM a Buy, Hold, or Sell?
Based on DXCM’s technical indicators, DXCM is a Sell.
    What is DXCM’s RSI (14)?
    DXCM’s RSI (14) is 40.19, which suggests DXCM is a Neutral.
      What is DXCM’s MACD?
      DXCM’s MACD is -2.33, which suggests DXCM is a Sell.
        What is DXCM’s 5-day moving average?
        DXCM’s 5-day moving average is 65.65, which suggests DXCM is a Buy.
          What is DXCM’s 20-day moving average?
          DXCM 20-day moving average is 66.89, which suggests DXCM is a Sell.
            What is DXCM’s 50-day moving average?
            DXCM’s 50-day moving average is 73.61, which suggests DXCM is a Sell.
              What is DXCM’s 200-day moving average?
              DXCM’s 200-day moving average is 78.86, which suggests DXCM is a Sell.
                What is DXCM’s Williams % R (14)?
                DXCM’s Williams % R (14) is -45.99, which suggests DXCM is a Buy.
                  What is DXCM’s CCI (14)?
                  DXCM’s CCI (14) is -67.95, which suggests DXCM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis